LYTIR

Insider · SEC Form 4 · Chief Financial Officer

Adam Laponis

Filed with the SEC as Laponis Adam; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $2.4M of TWST. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $2.4M in total.Jul: Insider sales $226KAug: Insider sales $273KOct: Insider sales $1.9MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $2.4M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. TWSTSold: Twist Bioscience Corp Oct 9, 2026 2,462 shares filed Oct 13, 2026 98,114 shares held directly after, as filed filing $385K
  2. TWSTSold: Twist Bioscience Corp Oct 2, 2026 8,057 shares filed Oct 5, 2026 100,576 shares held directly after, as filed filing $1.5M
  3. TWSTSold: Twist Bioscience Corp Aug 21, 2026 1,965 shares filed Aug 25, 2026 108,633 shares held directly after, as filed filing $273K
  4. TWSTSold: Twist Bioscience Corp Jul 9, 2026 2,399 shares filed Jul 13, 2026 110,276 shares held directly after, as filed filing $226K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.